Guangdong Tai'an Tang Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- The Company's stock will be delisted on the trading day following the end of the delisting adjustment period.
- The start date for the delisting adjustment period is June 14, 2024, lasting for fifteen trading days, with the last trading date expected to be July 4, 2024.
- The stock will trade for fifteen trading days during the delisting adjustment period. As of the date of this announcement (July 2, 2024), it is the 13th trading day, with 2 trading days remaining. The stock will be delisted after the trading period ends, and investors are advised to invest cautiously and be aware of risks.
- During the delisting adjustment period, the Company will not plan or implement any major asset restructuring matters.
- Investors, securities companies, and other market participants are advised to settle stock pledge repurchase, agreed repurchase, margin financing, securities lending, and Shenzhen Stock Connect businesses before the stock is delisted.
- For judicial freezing matters expiring between the stock delisting and the completion of the initial registration in the delisting sector, it is recommended that the competent authorities handle the renewal procedures in advance through the original enforcement channels before the stock is delisted.